Children & Families

Aducanumab is the first new drug approved to treat Alzheimer’s disease in nearly 20 years. But some in the medical community were stunned by the approval.

Race and Equity, Poverty and Class, Environmental Health, Healthcare Regulation and Reform, Mental Health, Chronic Disease

This story was written by SweSwe Aye while participating in the USC Annenberg Center for Health Journalism's 2021 California Fellowship.

Race and Equity, Poverty and Class, Environmental Health, Healthcare Regulation and Reform